Trial Profile
Relationships between pharmacokinetic and pharmacodynamic strategies for assessment of the risks for acute rejection and side effects of CellCept.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Mycophenolate mofetil (Primary)
- Indications Renal transplant rejection
- Focus Pharmacodynamics; Pharmacokinetics; Therapeutic Use
- Sponsors Roche
- 20 Oct 2008 Status changed from active, no longer recruiting to completed.
- 09 Jan 2008 New trial record.